Chrysin reduces hypercholesterolemia‐mediated atherosclerosis through modulating oxidative stress, microflora, and apoptosis in experimental rats

• Published in: Journal of food biochemistry 2022-11, Vol.46 (11), p.e14349-n/a
• Main Authors: Yuvaraj, Subramani, Sasikumar, Sundrasen, Puhari, Shanavas Syed Mohamed, Ramprasath, Tharmarajan, Baskaran, Nagarethinam, Vasudevan, Varadaraj, Selvam, Govindan Sadasivam
• Format: Article
• Language: English
• Subjects: Animals; Apoptosis; atherosclerosis; Atherosclerosis - drug therapy; Atherosclerosis - prevention & control; Body Weight; Chrysin; Flavonoids - pharmacology; gut microbiome; high‐fat diet; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology; Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use; hypercholesterolemia; Hypercholesterolemia - drug therapy; Male; Oxidative Stress; Rats; Rats, Wistar
• ISSN: 0145-8884; 1745-4514
• DOI: 10.1111/jfbc.14349

Chrysin (Chy) is known for various biological proprieties such as inhibitory effects on inflammation, cancer, oxidative stress, aging, and atherosclerosis. However, the hypolipidemic activity of Chy and its mechanistic action remains unclear in cardiovascular diseases (CVD). In this study, we focused on the hypolipidemic proprieties of Chy in hypercholesterolemia‐induced atherosclerosis. Male Wistar rats (150–220 g) were divided into four groups as follows: Group I control was fed with standard laboratory chow. Rats in Group II were fed a high‐fat diet (HFD) for 60 days. After 60 days of HFD, Group III rats received Chy (100 mg/kg body weight); Group IV rats received Atorvastatin (Atv; 10 mg/kg body weight) for 30 days. Biochemical studies showed Chy, Atv treatment decreased the activities of liver marker enzymes and the levels of Reactive Oxygen Species (ROS) and lipid profile. Gene expression analysis on nuclear factor erythroid 2‐related factor 2 (Nrf2) and its regulated genes were significantly reduced in the intestine and increased in the aorta by Chy and Atv. Gut microbial species such as Bacteroidetes, Lactobacillus, Enterococcus, and Clostridium leptum copy numbers were significantly increased by Chy and Atv treatment. In addition, Chy and Atv modulated the expression of inflammatory genes including TLR4, TNFα, NLRP3, and IL‐17 in the aorta and intestine compared with hypercholesterolemic control rats. Chy and Atv effectively increased the caspase‐3 mRNA expression in the intestine, but these decreased in the aorta. The present study concludes that by reducing oxidative stress and increasing gut microbial colonization, Chy may provide an effective therapeutic approach for the prevention of hypercholesterolemia‐mediated atherosclerosis. Practical applications Our study focused on a therapeutic model representing the clinical presentation of atherosclerosis in humans. Statins are commonly used in the treatment of cardiovascular complications, patients with hypercholesterolemia face difficulties in the continuation of statin therapy. The reason for statin discontinuation has been associated with toxicological effects. It is necessary to investigate the potentiality of the natural compound as an alternative medicine to statin with fewer side effects. The main theme of our study is to compare the therapeutic potential of Chy and Atv. Chy is a natural bioflavonoid that could be considered as an alternative medicinal compound to statins and to avoid toxic